Showing results (21-30 of 214) with videos related to
Sort By:
Pageof 22
Expert Opinion on Emerging Drugs|July 2, 2005
Developments in the treatment of leishmaniasis and trypanosomiasisPiero Olliaro, Janis Lazdins, Felipe GuhlAdvances in Parasitology|June 1, 2006
Chemotherapy in the treatment and control of leishmaniasisJorge Alvar, Simon Croft, Piero OlliaroThe Lancet. Infectious Diseases|November 25, 2006
Malaria in adolescence: burden of disease, consequences, and opportunities for interventionDavid G Lalloo, Peju Olukoya, Piero OlliaroThe Journal of Antimicrobial Chemotherapy|January 7, 2014
The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)Piero Olliaro, Petra Delgado-Romero, Jennifer KeiserTropical Medicine & International Health : TM & IH|July 1, 2009
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, IndiaPiero Olliaro, Sarah Darley, Ramanan Laxminarayan, et al.Clinical Trials (London, England)|January 16, 2016
Trial design for evaluating novel treatments during an outbreak of an infectious diseaseJohn Whitehead, Piero Olliaro, Trudie Lang, et al.The Cochrane Database of Systematic Reviews|July 8, 2011
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaDavid Sinclair, Nithya Gogtay, Felicity Brand, et al.American Journal of Public Health|February 17, 2017
Engaging Human Rights in the Response to the Evolving Zika Virus EpidemicJennifer J K Rasanathan, Sarah MacCarthy, Debora Diniz, et al.Kinetoplastid Biology and Disease|April 26, 2007
Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006Farrokh Modabber, Pierre A Buffet, Els Torreele, et al.Malaria Journal|September 18, 2007
Ensuring sustained ACT production and reliable artemisinin supplyJean-Marie Kindermans, Jacques Pilloy, Piero Olliaro, et al.Pageof 22